Evidence map›Paper›PMID 32025035›Full record

ArticleNature2020

SPEN integrates transcriptional and epigenetic control of X-inactivation.

François Dossin, Inês Pinheiro, Jan J Żylicz, Julia Roensch, Samuel Collombet, Agnès Le Saux, Tomasz Chelmicki, Mikaël Attia, Varun Kapoor, Ye Zhan and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 213 citations in OpenAlex.

  1. Review
  2. Review
  3. SPEN inactivation drives resistance to androgen receptor pathway inhibitors in metastatic prostate cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Xist in X chromosome inactivation: mechanisms and disease relevance.Cell communication and signaling : CCS · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

François DossinEuropean Molecular Biology Laboratory, Director's Unit, Heidelberg, Germany.
Inês Pinheiro *Institut Curie, PSL Research University, CNRS UMR3215, INSERM U934, UPMC Paris-Sorbonne, Paris, France.
Jan J Żylicz *Institut Curie, PSL Research University, CNRS UMR3215, INSERM U934, UPMC Paris-Sorbonne, Paris, France.
Julia RoenschInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, UPMC Paris-Sorbonne, Paris, France.
Samuel CollombetEuropean Molecular Biology Laboratory, Director's Unit, Heidelberg, Germany.
Agnès Le SauxInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, UPMC Paris-Sorbonne, Paris, France.
Tomasz ChelmickiInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, UPMC Paris-Sorbonne, Paris, France.
Mikaël AttiaInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, UPMC Paris-Sorbonne, Paris, France.
Varun KapoorInstitut Curie, PSL Research University, CNRS UMR3215, INSERM U934, UPMC Paris-Sorbonne, Paris, France.
Ye ZhanProgram in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
Florent DingliInstitut Curie, PSL Research University, Centre de Recherche, Laboratoire de Spectrométrie de Masse Protéomique, Paris, France.
Damarys LoewInstitut Curie, PSL Research University, Centre de Recherche, Laboratoire de Spectrométrie de Masse Protéomique, Paris, France.
Thomas MercherINSERM U1170, Gustave Roussy Institute, Université Paris-Sud, Villejuif, France.
Job DekkerProgram in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
Edith HeardEuropean Molecular Biology Laboratory, Director's Unit, Heidelberg, Germany. edith.heard@embl.org.
Centre National de la Recherche Scientifique · FREuropean Molecular Biology Laboratory · DEUniversité Paris Sciences et Lettres · FRHoward Hughes Medical Institute · USUniversité Paris-Sud · FRUniversity of Massachusetts Chan Medical School · US

Funding

Structural Annotation of the Human GenomeR01HG003143 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Job Dekker · 2003 to 2026
$15.4M
European Research Council 671027NHGRI NIH HHS R01 HG003143Wellcome Trust 201369/Z/16/Z
6 · The paper itself

Abstract

Xist represents a paradigm for the function of long non-coding RNA in epigenetic regulation, although how it mediates X-chromosome inactivation (XCI) remains largely unexplained. Several proteins that bind to Xist RNA have recently been identified, including the transcriptional repressor SPEN

Indexed as

Epigenesis, GeneticGene SilencingTranscription, GeneticAnimalsBlastocystChromatinDNA-Binding ProteinsEmbryo, MammalianEmbryonic Stem CellsEnhancer Elements, GeneticFemaleHistone DeacetylasesMaleMethylationMicePromoter Regions, GeneticChromatinDNA-Binding ProteinsHistone DeacetylasesRNA-Binding ProteinsRNA, Long NoncodingSpen protein, mouseXIST non-coding RNA

Identifiers

PMID32025035
PMCPMC7035112
OpenAlexW3005467454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.